Orofacial herpes and other localizations (genital herpes and neonatal herpes excluded);Herpès oro-facial, autres localisations herpétiques (herpès génital et néonatal exclus)

Annales de Dermatologie et de Venereologie

Volumn 129, Issue 4 II, 2002, Pages 494-506

  Martin, L ^a  

^a CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

10 UNDECENOIC ACID; ACICLOVIR; ANTIVIRUS AGENT; BEHENYL ALCOHOL; BETA INTERFERON; FOSCARNET; IDOXURIDINE; PENCICLOVIR; TETRACAINE; TRIFLURIDINE; VIDARABINE;

ANUS DISEASE; COCHRANE LIBRARY; CONFERENCE PAPER; EMBASE; ESTHETIC SURGERY; GINGIVA DISEASE; HAND INFECTION; HERPES LABIALIS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HUMAN; MEDLINE; OROFACIAL INFECTION; PATHOPHYSIOLOGY; RECURRENT INFECTION; SPORT; STOMATITIS; TRIGEMINAL NERVE; VIRUS EXCRETION; VIRUS REACTIVATION;

ACYCLOVIR; ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANTIVIRAL AGENTS; FACIAL DERMATOSES; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; IMMUNOCOMPETENCE; STOMATITIS, HERPETIC; VIRUS ACTIVATION;

EID: 0036270612     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (104)

1. Herpes simplex: Evolving concepts
2. Physiopathologie de l'infection à virus herpès simplex
3. Herpes simplex virus infections
4. The herpes simplex problem
5. Herpès simplex virus: Les mécanismes des phases de latence et de réactivation
6. Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection
7. Sero-epidemiological and sociological patterns of herpes simplex virus infection in the world
8. A cross-sectional study of herpes simplex virus types 1 and 2 in college students: Occurrence and determinants of infection
9. A 15-year surveillance study of antibodies to herpes simplex virus types 1 and 2 in a cohort of young girls
10. Prevalence of antibodies to herpes simplex virus types 1 and 2, Epstein-Barr virus and cytomegalovirus in teenage girls
11. Seroprevalence of herpes simplex virus infections in a family medicine clinic
12. Relationship between antibodies to herpes simplex virus (HSV) and symptoms of HSV infections
13. Seroprevalence of herpes simplex virus types 1 and 2 and cytomegalovirus in adolescents
14. A prospective study of new infections with herpes simplex virus type 1 and type 2
15. Infections with herpes simplex viruses
16. Herpes simplex type 1 infections in group day care
17. The natural history of primary herpes simplex type 1 gingivostomatitis in children
18. An outbreak of herpes simplex virus type 1 gingivostomatitis in a dental hygiene practice
19. Lack of oral HSV2 in a college student population
20. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type
21. Risk factors for sexual transmission of genital herpes
22. Herpes simplex virus type 2 in the United States, 1976 to 1994
23. Mucocutaneous infections with herpes simplex virus and their management
24. Prevalence of recurrent herpes labialis and aphthous ulcers among young adults on six continents
25. Cross-sectional study of recurrent herpes labialis. Prevalence and risk factors
26. Herpès labial et génital en médecine générale
27. Pathogenesis of herpes simplex labialis: Excretion of virus in the oral cavity
28. Detection of herpes simplex virus (HSV) in the saliva from 1,000 oral surgery outpatients by the polymerase chain reaction (PCR) and virus isolation
29. Clinical epidemiology of symptomatic primary herpetic infection in children. A study of 50 cases
30. Herpes simplex virus latency and the immune response
31. Prophylactic chemotherapy with acyclovir for recurrent herpes simplex labialis
32. Herpes simplex virus-specific immune responses in subjects with frequent and infrequent orofacial recrudescences
33. The natural history of recurrent herpes simplex labialis
34. The natural history of ultraviolet radiation-induced herpes simplex labialis and response to therapy with peroral and topical formulations of acyclovir
35. Use of valacyclovir for herpes simplex virus-1 (HSV1) prophylaxis after facial resurfacing: A randomized clinical trial of dosing regimens
36. Famciclovir prophylaxis of herpes simplex virus reactivation after laser skin resurfacing
37. Famciclovir as antiviral prophylaxis in laser resurfacing procedures
38. Preventive therapy of herpes labialis associated with trigeminal surgery
39. Herpes labialis in parturients receiving epidural morphine following cesarean section
40. Herpes simplex labialis after epidural or parenteral morphine: A randomized prospective trial in an Australian obstetric population
41. Prevention of ultraviolet-light-induced herpes labialis by sunscreen
42. Recrudescent herpes simplex infection mimicking primary herpetic gingivostomatitis
43. The clinical characteristics of intraoral herpes simplex virus infection in 52 immunocompetent patients
44. Recurrent and continuous erythema multiforme - A clinical and immunological study
45. Recurrent erythema multiforme
46. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes
47. Understanding the pathogenesis of HSV-associated erythema multiforme
48. Herpes simplex virus infection of the hand: A profile of 79 cases
49. Herpetic whitlow: An occupational disease of practicing dentists
50. Nosocomial herpetic infections in a pediatric intensive care unit
51. Transmission of herpes simplex virus type 1 infection in rugby players
52. An outbreak of herpes gladiatorium at a high-school wrestling camp
53. Kaposi's varicelliform eruption
54. Increasing incidence of eczema herpeticum: Analysis of seventy-five cases
55. Surinfection herpétique du pemphigus
56. Revisit to Kaposi's varicelliform eruption: Role of IL-4
57. Comparison of the association with eczema herpeticum in the two predominant genotypes of herpes simplex virus type 1
58. Virus characterization studies in eczema herpeticum
59. Herpes simplex virus type 1 as a cause of widespread intracorneal blistering of the lower limbs
60. Treatment of herpes simplex gingivostomatitis with aciclovir in children: A randomised double blind placebo controlled study
61. La gingivo-stomatite herpétique de l'enfant: Essai contrôlé aciclovir versus placebo
62. Oral acyclovir and herpes labialis: A randomized, double-blind, placebo-controlled study
63. Treatment of recurrent herpes simplex labialis with oral acyclovir
64. Failure of topical acyclovir in ointment to penetrate human skin
65. Failure of acyclovir cream in treatment of recurrent herpes labialis
66. Herpes labialis treatment with acyclovir 5 p. 100 modified aqueous cream: A double-blind, randomized trial
67. Successful treatment of herpes labialis with topical acyclovir
68. Topical acyclovir therapy in patients with recurrent orofacial herpes simplex infections
69. Penciclovir cream for the treatment of herpes simplex labialis
70. Efficacy and safety of foscarnet for recurrent orolabial herpes: A multicentre randomized double-blind study
71. Early application of topical 15 p. 100 idoxuridine in dimethyl sulfoxide shortens the course of herpes simplex labialis: A multicenter placebo-controlled trial
72. n-docosanol 10 p. 100 cream in the treatment of recurrent herpes labialis. A randomised, double-blind, placebo-controlled study
73. Topical undecylenic acid for herpes simplex labialis: A multicenter, placebo-controlled trial
74. A double-blind, placebo-controlled study of topical tetracaine in the treatment of herpes labialis
75. Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis
76. Topical treatment of recurrent mucocutaneous herpes with ascorbic acid-containing solution
77. Prophylaxis against herpes labialis with acyclovir cream. A placebo-controlled study
78. Prophylactic topical acyclovir for frequent recurrent herpes simplex infection with and without erythema multiforme
79. Placebo-controlled trial of topical interferon in labial and genital herpes
80. Low-intensity laser therapy is an effective treatment for recurrent herpes simplex infection. Results from a randomized double-blind placebo-controlled study
81. Oral acyclovir in the suppression of recurrent non-genital herpes simplex virus infection
82. Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial
83. Herpes labialis in skiers. Randomized clinical trial of acyclovir cream versus placebo
84. Acyclovir prevents reactivation of herpes simplex labialis in skiers
85. Oral acyclovir in prevention of herpes labialis. A randomized, double-blind, multi-centered clinical trial
86. Peroral famciclovir in the treatment of experimental ultraviolet radiation-induced herpes simplex labialis: A double-blind, dose-ranging, placebo-controlled, multicenter trial
87. Combination treatment with famciclovir and a topical corticosteroid gel versus famciclovir alone for experimental ultraviolet radiation-induced herpes simplex labialis: A pilot study
88. Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: A randomized, double-blind, placebo-controlled trial
89. Effect of foscarnet cream on experimental UV radiationinduced herpes labialis
90. Assessment of the effect of a sunblock stick in the prevention of solar-simulating ultraviolet light-induced herpes labialis
91. Immunotherapy with transfer factor of recurrent herpes simplex type 1
92. Effect of anti-herpes specific transfer factor
93. Suppression of herpes simplex virus infections with oral lithium carbonate-a possible antiviral activity
94. Failure of lysine in frequently recurrent herpes simplex infection. Treatment and prophylaxis
95. Multicentre clinical trial with herpes simplex virus vaccine in recurrent herpes infection
96. A double-blind, placebo-controlled trial of continuous acyclovir therapy in recurrent erythema multiforme
97. Prophylactic oral acyclovir in outbreaks of primary herpes simplex virus type 1 infection in a closed community
98. Herpes simplex virus vaccines
99. Oral acyclovir therapy of recurrent herpes simplex virus type 2 infection of the hand
100. Treatment of eczema herpeticum with oral acyclovir
101. The clinical evaluation of agents for the prophylaxis and treatment of herpesvirus infections
102. Iontophoresis of vidarabine monophosphate for herpes orolabialis
103. A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis
104. Les inhibiteurs nucléosidiques et non nucléosidiques du virus herpès simplex